Addressing geographical variation in the progression of non-communicable diseases in Peru: The CRONICAS cohort study protocol

BMJ Open

Volumn 2, Issue 1, 2012, Pages

  Miranda, J Jaime ^a,b   Bernabe Ortiz, Antonio ^a,b   Smeeth, Liam ^a,c   Gilman, Robert H ^a,d,e   Checkley, William ^a,d,f   Casas, Juan P ^g   Smith, George Davey ^g   Ebrahim, Shah ^g   Gamboa, Raúl ^g   García, Héctor H ^g   Huicho, Luis ^g   Málaga, Germán ^g   Montori, Víctor M ^g   Diette, Gregory B ^g   León Velarde, Fabiola ^g   Rivera, María ^g   Wise, Robert A ^g   Sacksteder, Katherine ^g  

^a CRONICAS CENTER OF EXCELLENCE IN CHRONIC DISEASES   (Peru)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e ASOCIACIÓN BENÉFICA PRISMA   (Peru)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY COMPOSITION; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; DISEASE COURSE; DISEASES; FEMALE; GEOGRAPHIC DISTRIBUTION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NONCOMMUNICABLE DISEASE; PERU; PREVALENCE; RISK FACTOR; SOCIAL STATUS; SPIROMETRY;

EID: 84863274453     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2011-000610     Document Type: Article

References (60)

1. Adeyi O, Smith O, Robles S. Public Policy and the Challenge of Chronic Noncommunicable Diseases. Washington D.C: World Bank, 2007.
2. World Health Organization. Preventing Chronic Diseases: a Vital Investment. WHO Global Report. Geneva: World Health Organization, 2005.
3. Wang L, Kong L, Wu F, et al. Preventing chronic diseases in China. Lancet 2005;366:1821-4. (Pubitemid 41642648)
4. Strong K, Mathers C, Leeder S, et al. Preventing chronic diseases: how many lives can we save? Lancet 2005;366:1578-82. (Pubitemid 41540116)
5. Srinath Reddy K, Shah B, Varghese C, et al. Responding to the threat of chronic diseases in India. Lancet 2005;366:1744-9. (Pubitemid 41587455)
6. Horton R. The neglected epidemic of chronic disease. Lancet 2005;366:1514. (Pubitemid 41540102)
7. Epping-Jordan JE, Galea G, Tukuitonga C, et al. Preventing chronic diseases: taking stepwise action. Lancet 2005;366:1667-71. (Pubitemid 41552423)
8. Lim SS, Gaziano TA, Gakidou E, et al. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet 2007;370:2054-62. (Pubitemid 50007974)
9. Horton R. Chronic diseases: the case for urgent global action. Lancet 2007;370:1881-2. (Pubitemid 350192635)
10. Gaziano TA, Galea G, Reddy KS. Scaling up interventions for chronic disease prevention: the evidence. Lancet 2007;370:1939-46. (Pubitemid 350192634)
11. Beaglehole R, Ebrahim S, Reddy S, et al. Prevention of chronic diseases: a call to action. Lancet 2007;370:2152-7. (Pubitemid 50007975)
12. Abegunde DO, Mathers CD, Adam T, et al. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007;370:1929-38. (Pubitemid 350192633)
13. Samb B, Desai N, Nishtar S, et al. Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries. Lancet 2011;376:1785-97.
14. Mbanya JC, Squire SB, Cazap E, et al. Mobilising the world for chronic NCDs. Lancet 2011;377:536-7.
15. Geneau R, Stuckler D, Stachenko S, et al. Raising the priority of preventing chronic diseases: a political process. Lancet 2011;376:1689-98.
16. Beaglehole R, Horton R. Chronic diseases: global action must match global evidence. Lancet 2011;376:1619-21.
17. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet 2011;377:1438-47.
18. Alwan A, Maclean DR, Riley LM, et al. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet 2011;376:1861-8.
19. Anderson GF, Chu E. Expanding prioritieseconfronting chronic disease in countries with low income. N Engl J Med 2007;356:209-11. (Pubitemid 46143222)
20. Ebrahim S, Smeeth L. Non-communicable diseases in low and middle-income countries: a priority or a distraction? Int J Epidemiol 2005;34:961-6. (Pubitemid 41535535)
21. Perel P, Casas JP, Ortiz Z, et al. Noncommunicable diseases and injuries in Latin America and the Caribbean: time for action. PLoS Med 2006;3:-344.
22. Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanisation. Circulation 2001;104:2746-53. (Pubitemid 33108145)
23. Bloom DE, Cafiero ET, Jané -Llopis E, et al. The Global Economic Burden of Non-Communicable Diseases. Geneva: World Economic Forum, 2011.
24. Suhrcke M, Nugent RA, Stuckler D, et al. Chronic disease: An Economic Perspective. London: Oxford Health Alliance, 2006.
25. Leeder S, Raymond S, Greenberg H, et al. A Race against Time: The Challenge of Cardiovascular Disease in Developing Economies. New York: The Earth Institute, Columbia University, 2004.
26. Cerqueira MT, Cravioto A, Dianis N, et al. Global response to non-communicable disease. BMJ 2011;342:d3823.
27. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52. (Pubitemid 39208455)
28. Yusuf S, Vaz M, Pais P. Tackling the challenge of cardiovascular disease burden in developing countries. Am Heart J 2004;148:1-4. (Pubitemid 38900473)
29. World Health Organization. Prioritized Research Agenda for Prevention and Control of Noncommunicable Diseases. Geneva, Switzerland: World Health Organization, 2008.
30. Perel P, Miranda JJ, Ortiz Z, et al. Relation between the global burden of disease and randomized clinical trials conducted in Latin America published in the five leading medical journals. PLoS One 2008;3:-1696.
31. PAHO-Peru. Health in Americasd2007 Edition. Washington D.C: PAHO, 2007.
32. Jacoby E, Goldstein J, Lopez A, et al. Social class, family, and lifestyle factors associated with overweight and obesity among adults in Peruvian cities. Prev Med 2003;37:396-405. (Pubitemid 37315551)
33. Medina-Lezama J, Zea-Diaz H, Morey-Vargas OL, et al. Prevalence of the metabolic syndrome in Peruvian Andean hispanics: the PREVENCION study. Diabetes Res Clin Pract 2007;78:270-81. (Pubitemid 47451536)
34. Goldstein J, Jacoby E, del Aguila R, et al. Poverty is a predictor of non-communicable disease among adults in Peruvian cities. Prev Med 2005;41:800-6. (Pubitemid 41400048)
35. Yusuf S, Ounpuu S. Tackling the growing global burden of atherosclerotic cardiovascular diseases. Eur J Cardiovasc Prev Rehabil 2003;10:236-9. (Pubitemid 37433487)
36. Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005;366:1875-81. (Pubitemid 41690116)
37. Menezes AM, Lopez MV, Hallal PC, et al. Prevalence of smoking and incidence of initiation in the Latin American adult population: the PLATINO study. BMC Public Health 2009;9:151.
38. Miranda JJ, Gilman RH, Smeeth L. Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru. Heart 2011;97:787-96.
39. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50. (Pubitemid 47321907)
40. Torres-Duque C, Maldonado D, Perez-Padilla R, et al. Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc 2008;5:577-90. (Pubitemid 352031530)
41. Daar AS, Singer PA, Persad DL, et al. Grand challenges in chronic non-communicable diseases. Nature 2007;450:494-6. (Pubitemid 350190238)
42. World Health Organization. WHO STEPwise Approach to Surveillance (STEPS). STEPS Manual. Geneva, Switzerland. http://www.who.int/chp/steps/manual/en/ index.html
43. Coleman A, Steel S, Freeman P, et al. Validation of the Omron M7 (HEM-780-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol. Blood Pressure Monit 2008;13:49-54.
44. Heald CL, Fowkes FG, Murray GD, et al. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis 2006;189:61-9. (Pubitemid 44441297)
45. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38. (Pubitemid 41079078)
46. Ferguson GT, Enright PL, Buist AS, et al. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 2000;117:1146-61. (Pubitemid 30228377)
47. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-52. (Pubitemid 37553153)
48. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(Suppl 1):S5-20.
49. Lamprecht B, Schirnhofer L, Kaiser B, et al. Subjects with discordant airways obstruction: lost between spirometric definitions of COPD. Pulm Med 2011;2011:780215.
50. Global Initiative for Chronic Obstructive Lung Disease (GOLD). http:// www.goldcopd.org (accessed 30 Sep 2011).
51. Miller MR, Hankinson J, Brusasco V, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005;26:319-38. (Pubitemid 41079078)
52. Miranda JJ, Gilman RH, Garcia HH, et al. The effect on cardiovascular risk factors of migration from rural to urban areas in Peru: PERU MIGRANT study. BMC Cardiovasc Disord 2009;9:23.
53. Morice AH, Celli B, Kesten S, et al. COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT). Respir Med 2010;104:1659-67.
54. World Health Organization. The WHO Standard Population. Geneva: World Health Organization. https://apps.who.int/infobase/help.aspx?helpid=293
55. Cohen J. Statistical Power Analysis in the Behavioral Sciences. 2nd edn. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc., 1988.
56. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org
57. Departamento de Ciência e Tecnologia, Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Ministé rio da Saûde. ELSA Brasil: the greatest epidemiological study in Latin America [In Portuguese]. Rev Saude Publica. 2009 Feb;43(1).http://dx.doi.org/10.1590/S0034- 89102009000100028.http://www.scielosp.org/scielo.php?script=sci-isoref&pid= S0034-89102009000100028&lng=en&tlng=pt.
58. Rubinstein A, Irazola V, Poggio R, et al. Detection and follow-up of cardiovascular disease and risk factors in the Southern Cone of Latin America: the CESCAS I study. BMJ Open 2011;1:-000126.
59. Narayan KM, Ali MK, del Rio C, et al. Global noncommunicable diseaseselessons from the HIV-AIDS experience. N Engl J Med 2011;365:876-8.
60. Noncommunicable Diseases Country Profile 2011-WHO Global Report. Geneva, Switzerland: WHO, 2011.